After Cowboys playmaker KaVontae Turpin turned in what was the fourth-most productive day from scrimmage in his career–with 47 receiving yards and six more on the ground, plus a touchdown–he was left ...
One knockout on July 18 stood above the rest at Power Slap 14. The UFC is set to make its long-awaited return to New Orleans later today where Dustin Poirier will compete for the final time in his ...
Medicare will typically cover TURP surgery if a doctor determines it is medically necessary for treating benign prostatic hyperplasia (BPH). Coverage varies based on hospital status. Medicare Part A ...
Medicare usually covers TURP surgery, which doctors may perform at an ambulatory surgical center or in a hospital. Transurethral resection of the prostate (TURP) is a medical procedure that may help ...
The benefits of laser surgery vs TURP for BPH treatment vary among patients with stage 1-5 CKD. For patients with chronic kidney disease (CKD) undergoing a procedure for benign prostatic hyperplasia ...
During lovemaking, young men often ask women, “Did you come?” Gentlemen, if you ask this question, see my previous post, “How to Recognize Women’s Orgasms.” But shortly after orgasm, many older men ...
Elise Kozal spent the better part of her college years with a burning bladder and urethra—a sensation that would send her to the bathroom constantly only to feel, frustratingly, as if she could never ...
In patients with suspected muscle-invasive bladder cancer (MIBC), definitive treatment can be expedited by adding multi-parametric magnetic resonance imaging (mpMRI) to flexible cystoscopic biopsy at ...
Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...
Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late detection often requires major surgeries such as ...
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results We conducted a prospective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results